This document summarizes the key information about the medication atorvastatin (Lipitor) including its classification, dose, route of administration, time/frequency, mechanism of action, indications, contraindications, warnings, interactions, common side effects, and lab value alterations. It provides nursing implications for properly administering, monitoring, and educating patients about this medication which is used for primary prevention of cardiac disease by inhibiting cholesterol synthesis. Nurses should assess for reasons to hold the medication and evaluate its effectiveness by monitoring lipid levels.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
This document summarizes the key information about the medication atorvastatin (Lipitor) including its classification, dose, route of administration, time/frequency, mechanism of action, indications, contraindications, warnings, interactions, common side effects, and lab value alterations. It provides nursing implications for properly administering, monitoring, and educating patients about this medication which is used for primary prevention of cardiac disease by inhibiting cholesterol synthesis. Nurses should assess for reasons to hold the medication and evaluate its effectiveness by monitoring lipid levels.
This document summarizes the key information about the medication atorvastatin (Lipitor) including its classification, dose, route of administration, time/frequency, mechanism of action, indications, contraindications, warnings, interactions, common side effects, and lab value alterations. It provides nursing implications for properly administering, monitoring, and educating patients about this medication which is used for primary prevention of cardiac disease by inhibiting cholesterol synthesis. Nurses should assess for reasons to hold the medication and evaluate its effectiveness by monitoring lipid levels.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
This document summarizes the key information about the medication atorvastatin (Lipitor) including its classification, dose, route of administration, time/frequency, mechanism of action, indications, contraindications, warnings, interactions, common side effects, and lab value alterations. It provides nursing implications for properly administering, monitoring, and educating patients about this medication which is used for primary prevention of cardiac disease by inhibiting cholesterol synthesis. Nurses should assess for reasons to hold the medication and evaluate its effectiveness by monitoring lipid levels.
Copyright:
Attribution Non-Commercial (BY-NC)
Available Formats
Download as DOC, PDF, TXT or read online from Scribd
Generic Name Trade Name Classification Dose Route Time/frequency
atorvastatin Lipitor CAD Lipid lowering 10 mg PO Every night Peak Onset Duration For IV meds, compatibility with IV drips and /or solutions N/A N/A 20-30 hrs N/A (Why med ordered) Nursing Implications (what to focus on) Primary prevention of cardiac Contraindications/warnings/interactions Disease. Hypersensitivity, use cautiously in pts with liver problems. Mechanism of action and indications Common side effects Inhibit an enzyme (HMG-CoA) Dizziness, headaches, insomnia, weakness, chest pain, peripheral reductase, which is responsible for edema, blurred vision. catalyzing an early step in the synthesis of cholesterol. Interactions with other patient Lab value alterations caused by medicine drugs, OTC or herbal medicines (ask patient specifically) Evaluate serum cholesterol and triglyceride levels before initiating, 4- 6 weeks of therapy, and periodically after. Monitor liver function Pt on …… I see no known drug tests, including AST. interactions …. Possible grapefruit juice …. Be sure to teach the patient the following about this medication Take at same time each day before bedtime that the pills should not be broken or crushed or chewed because there extended release capsules.
Nursing Process- Assessment Evaluation
Assessment Why would you hold or not give this Check after giving (Pre-administration med? Check for increases in HDL’s and assessment) Obtain a If patient develops muscle tenderness Decreases in LDL’s and for dietary history, during therapy. Monitor CK levels. IF decreases in triglyceride levels. especially with regard CK levels are >10 times the upper limit to fat consumption. of normal or if myopathy occurs. Therapy should be discontinued.